Illegal Bioengineering Labs in the U.S. ties to tech Surveillance and Disruptor Agents

Over the past few years, several incidents involving unauthorized or illegal biolabs in the U.S. have come to light, primarily through local code enforcement, health department inspections, and federal investigations. These cases often involve improper storage of biological materials, unlicensed operations, and connections to foreign entities, sparking concerns about biosecurity and potential misuse. However, investigations have not confirmed any active biological weapons development or deployment in these instances—most appear tied to unregulated medical testing or research. Below is a high-level overview of notable cases since around 2020, based on public reports and official findings.

Reedley, California (Discovered in Late 2022/Early 2023)

• A clandestine lab operated by Prestige Biotech Inc. (linked to Universal Meditech Inc.) was uncovered in a warehouse in Reedley, Fresno County, after a code enforcement officer noticed an illegal garden hose connection.

  
  

  The facility, which had been running without permits since October 2022, contained nearly 1,000 lab mice (including about 200 dead ones genetically modified to carry COVID-19), hundreds of vials of infectious agents (e.g., samples of HIV, hepatitis, malaria, chlamydia, rubella, dengue, and COVID-19), unlabeled bodily fluids, and hazardous chemicals.

  
  

  No criminal activity related to bioweapons was found, but the lab violated local, state, and federal codes for biohazard management and medical waste.

  
  

• The company was Chinese-owned, with ties to a fugitive named Jia Bei Zhu (also known as Jesse Zhu or David He), who faced a $330 million Canadian judgment for intellectual property theft.

  
  

   Zhu and a partner were later indicted on federal charges for conspiracy, wire fraud, and distributing misbranded COVID-19 test kits imported illegally from China.

  
  

  Cleanup involved the CDC, FBI, and local health officials, costing taxpayers significantly, and the lab received over $500,000 in U.S. funds for test production despite its illegality.

  
  

• A congressional report by the House Select Committee on the Chinese Communist Party highlighted the incident as a biosecurity risk, noting poor federal oversight of non-government labs and recommending enhanced monitoring.

  
  

  It fueled online speculation about foreign bioweapon threats, though officials emphasized no public health danger.

  
  

Las Vegas, Nevada (Discovered in Early 2026)

• In a case linked to the Reedley lab, the FBI and Las Vegas Metro Police raided a home in northeast Las Vegas tied to the same LLC and individuals (including Jia Bei Zhu).

  
  

  Over 1,000 samples of biological materials were found, along with potential pathogens like HIV, tuberculosis, and malaria.

  
  

  A second location was searched but yielded no lab.

• The operation mirrored Reedley, involving misbranded medical devices and fraudulent test kits.

  
  

  Zhu, already in custody from the California case, is implicated, with alleged ties to Chinese military-civil fusion programs.

  
  

  This prompted calls for congressional hearings on bipartisan biosecurity legislation.

  
  

  As of early 2026, investigations are ongoing, with reports of up to 20 related sites under scrutiny.

  
  

Other Related or Accidental Incidents

• While not strictly "illegal biolabs," there have been mishaps in regulated U.S. facilities that raised biosecurity alarms. For example, from 2005–2015, the U.S. Army's Dugway Proving Ground accidentally shipped live anthrax samples to dozens of labs across the U.S. and abroad due to flawed inactivation processes.

  
  

  In 2014, toxic Burkholderia bacteria escaped a BSL-3 lab at Tulane National Primate Research Center, infecting outdoor monkeys via contaminated clothing.

  
  

  These were accidents, not intentional, but highlight vulnerabilities in handling select agents.

• Broader concerns: A 2023 TIME article discussed the proliferation of unregulated "invisible" biolabs outside federal oversight, using the Reedley case as an example.

  
  

  USA TODAY investigations have documented hundreds of safety violations in high-containment labs since the early 2000s, though most are in legal facilities.

  
  

These incidents underscore gaps in U.S. biosecurity oversight for private or hidden labs, especially those with international ties. Federal agencies like the CDC and FBI have emphasized that while risks exist, no imminent threats to public safety were identified in the illegal cases. Efforts to strengthen regulations, such as proposed bills for better tracking of non-federal research, are underway.

For biological weapons specifically, no confirmed attacks or programs have occurred in the U.S. since the 2001 anthrax letters (Amerithrax)

#HALOC